Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4434_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Foreword
- •Foreword
- •Preface
- •Acknowledgment
- •Contents
- •About the Editors
- •1.1 Introduction
- •1.6 Dissection Procedure
- •1.6.2 Dissection Guide
- •1.9 Conclusion
- •References
- •2.1 Introduction
- •1.5.3 Sentinel Lymph Node Biopsy
- •2.3.1 Oral Cavity Surgery
- •2.3.2 Pharyngeal Surgery
- •2.3.3 Transoral Robotic Surgery (TORS)
- •2.4 Laryngeal Surgery
- •2.6 Salivary Gland Surgery
- •2.7 Thyroid Gland Surgery
- •2.8 Neck Dissection
- •2.9.1 Paediatric Surgery
- •2.10 Anatomical Versus Surgical Landmarks
- •2.13 Conclusion
- •References
- •3.1 Introduction
- •3.6.1 Pharynx
- •3.6.2 Nasopharyngeal Surgery
- •3.6.6 Temporal Bone Surgery
- •3.7 Conclusion
- •References
- •4.2.1 Perineural Tumour Spread
- •4.2.2 Carotid Artery Involvement
- •4.3.1 Oral Cavity
- •4.3.2 Nasopharynx
- •4.3.3 Oropharynx
- •4.3.4 Hypopharynx
- •4.3.5 Larynx
- •4.4.1 Oral Cavity Squamous Cell Carcinoma
- •4.4.2 Oropharyngeal Squamous Cell Carcinoma
- •4.4.3 Nasopharyngeal Squamous Cell Carcinoma
- •4.4.4 Non-HPV Oropharyngeal Squamous Cell Carcinoma
- •4.4.5 Unknown Primary Tumours
- •4.5 Lymph Nodes
- •4.5.1 Introduction
- •4.5.2.1 Clustering
- •4.5.2.2 Morphology
- •4.5.2.3 Inhomogeneity
- •4.5.2.4 Size
- •4.5.2.5 Lymphatic Drainage
- •4.6 Advanced Imaging
- •4.6.1 Elastography
- •4.6.2 DWI-MRI
- •4.7.1 Introduction
- •4.11 Cross-Sectional Imaging
- •References
- •5: Approach Towards Oral Cavity Cancers
- •5.1 Introduction
- •5.3 Diagnostic Evaluation
- •5.8.2.1 Access-Incision Planning
- •5.8.3 Surgical Techniques
- •5.8.3.1 Anaesthesia Considerations
- •5.8.4.1 Peroral Wide Local Excision
- •5.8.5.1 Access Osteotomy Through Mandibulotomy
- •5.8.5.2 Surgical Steps
- •5.8.5.3 Pull-Through Approach
- •5.8.5.4 Oral Component
- •5.8.5.5 Neck Component
- •5.8.6.1 Peroral Wide Local Excision
- •5.8.6.2.1 Surgical Steps
- •5.8.11 Hard Palate (T1–T2 Lesion)
- •5.8.11.1 Upper Alveolectomy
- •References
- •6.1 Benign Oropharyngeal Tumours
- •6.1.1 Lingual Thyroid
- •6.1.2 Epidemiology
- •6.1.3 Clinical Presentation
- •6.1.4 Histology
- •6.1.5 Imaging
- •6.1.6 Blood Investigation
- •6.1.7 Treatment
- •6.1.8 Surgical Treatment
- •6.1.9 Non-surgical Treatment
- •6.2 Pleomorphic Adenoma
- •6.2.1 Diagnosis
- •6.4.8 Early Stage
- •6.4.9 Advanced Stage
- •6.4.10 Non-surgical Treatment
- •6.4.11 Case Illustration 1
- •6.4.12 Case Illustration 2
- •6.5 Benign Hypopharyngeal Tumours
- •6.5.1 Fibrolipoma
- •6.2.3 Treatment
- •6.2.4 Case Illustration 1
- •6.3 Papilloma
- •6.3.1 Epidemiology
- •6.3.2 Clinical Presentation
- •6.3.3 Histology
- •6.3.4 Treatment
- •6.4.1 Risk Factors
- •6.4.2 Clinical Presentation
- •6.4.3 Diagnosis
- •6.4.4 Histology
- •6.4.5 Imaging
- •6.4.6 Staging
- •6.4.7 Treatment
- •6.6.1 Epidemiology
- •6.6.2 Risk Factor
- •6.6.3 Clinical Presentation
- •6.6.4 Diagnosis
- •6.6.5 Blood Investigations
- •6.6.6 Imaging
- •6.6.8 Histology
- •6.6.9 Staging
- •6.6.9.1 Primary Tumour (T)
- •6.6.9.2 Regional Lymph Node (N)
- •6.6.9.3 Distant Metastasis (M)
- •6.6.9.4 Stage Groups
- •6.6.10 Treatment
- •6.6.10.1 Surgical
- •References
- •7.1 Introduction
- •7.2 Salvage Neck Dissection
- •7.3.2.1 Procedure
- •7.3.2.2 Advantages
- •7.3.2.3 Disadvantages
- •7.3.3.1 Procedure
- •7.3.3.2 Advantages
- •7.3.3.3 Disadvantages
- •7.4.1 Procedure
- •7.4.2 Advantages
- •7.4.3 Disadvantages
- •7.5.1 Procedure
- •7.5.2 Advantages
- •7.5.3 Disadvantages
- •7.6 Subtemporal-Preauricular Infratemporal Fossa Approach
- •7.6.1 Procedure
- •7.6.2 Advantages
- •7.6.3 Disadvantages
- •7.7 Facial Translocation
- •7.7.1 Procedure
- •7.7.2 Advantages
- •7.7.3 Disadvantages
- •7.8 Endoscopic Endonasal Transpterygoid Nasopharyngectomy (EETN)
- •7.8.1 Patient Selection
- •7.8.2 Surgical Technique
- •7.8.2.1 Nasoseptal Flap
- •7.8.2.2 Sinonasal Corridor
- •7.8.2.3 Posterior Septectomy
- •7.8.2.4 Inferior Sphenoidectomy
- •7.8.2.5 Transpterygoid Dissection
- •7.8.2.6 Tumour Extirpation
- •7.10 Miscellaneous
- •7.11 Conclusion
- •References
- •8.1 Introduction
- •8.6 Parotid Gland Surgery
- •8.6.1 Benign Parotid Tumour Surgery
- •8.6.2 Malignant Parotid Tumour Surgery
- •8.7.1.2 Skin Incision
- •8.7.1.4 Greater Auricular Nerve Preservation
- •8.7.1.8 Facial Nerve Branch Preservation
- •8.7.1.10 Homeostasis Control
- •8.7.1.12 Post-operative Follow-Up
- •8.7.2.1 Case Illustration 1
- •8.8 Complications Post Parotidectomy
- •8.9.2 Post-operative Assessment
- •8.12 Conclusion
- •References
- •9.1 Introduction
- •9.2.1 Recurrent Laryngeal Nerve
- •9.2.3 Berry’s Ligament
- •9.2.4 Parathyroid Gland Anatomy
- •9.2.5 Inferior Thyroid Artery
- •9.2.6 Zuckerkandl Tubercle
- •9.5 Retrosternal Thyroid Tumour
- •9.7 Intraoperative Neural Monitoring
- •9.9 Thyroid Lobectomy
- •9.9.1 Case Illustration 1: Completion Hemithyroidectomy
- •9.10 Conclusion
- •References
- •10.1 Introduction
- •10.2 Surgical Anatomy
- •10.3 Indications
- •10.4.1 Patient Preparation
- •10.4.2 Informed Consent
- •10.4.3 Preoperative Planning/Evaluation
- •10.4.4.1 Antibiotic
- •10.4.4.2 Systemic Corticosteroid
- •10.4.4.3 Topical Decongestants
- •10.4.4.4 Adrenaline
- •10.4.5 Anaesthesia
- •10.4.7 Image-Guided System (IGS)
- •10.5 Operative Techniques
- •10.5.1 Endoscopic Sinus Surgery
- •10.5.1.1 Uncinectomy
- •10.5.1.2 Middle Meatal Antrostomy (MMA)
- •10.5.1.3 Ethmoidal Bullectomy
- •10.5.1.4 Posterior Ethmoidectomy
- •10.5.1.5 Sphenoidotomy
- •10.5.1.6 Frontal Sinusotomy
- •10.6 Intraoperative Complication
- •10.6.1 Intranasal Complications
- •10.6.1.2 Arterial Injury
- •10.6.1.2.1 Sphenopalatine Artery
- •10.6.1.2.2 Anterior Ethmoidal Artery (AEA)
- •10.6.1.2.3 Posterior Ethmoidal Artery (PEA)
- •10.6.1.2.4 Internal Carotid Artery (ICA)
- •Call for Help
- •Interventional Radiologist/Endovascular
- •10.6.2 Intraorbital Complications
- •10.6.2.2 Orbital Emphysema (Grade I)
- •10.6.2.3 Intraorbital Haematoma (Grade I)
- •10.6.2.5 Extraocular Muscle Injury (Grade III)
- •10.6.2.6 Optic Nerve Injury (Grade III)
- •10.6.3 Intracranial Complications
- •10.6.3.1 CSF Leak
- •10.6.4 Post-operative Complication
- •10.6.4.1 Epistaxis
- •10.6.4.2 Nasal Synechia
- •10.6.4.3 Other Complications
- •References
- •11.1 Introduction
- •11.2 Anatomical Landmarks
- •11.3 Background
- •11.4 Patient’s Preparation
- •11.5 Equipment
- •11.6 Positioning
- •11.7 Preoperative Evaluation
- •11.8 Infrastructure Maxillectomy
- •11.9 Subtotal Maxillectomy
- •11.10 Total Maxillectomy
- •11.12 Transoral-Transnasal Endoscopic Maxillectomy
- •11.13 Endoscopic-Assisted Transfacial Maxillectomy
- •11.14 Conclusion
- •References
- •12.1 Introduction
- •12.3 Laryngeal Diseases
- •12.4 Supraglottic Carcinoma
- •12.5 Glottic Carcinoma
- •12.6 Subglottic Carcinoma
- •12.8 Surgical Treatment
- •12.9.1 Skin Incision
- •12.9.5 Larynx Skeletonization
- •12.10 Open Partial Horizontal Laryngectomy (OPHL)
- •12.10.1.1 Surgical Technique
- •12.10.2.1 Surgical Technique
- •12.10.3.1 Surgical Technique
- •12.11 Total Laryngectomy
- •12.11.1 Surgical Technique
- •12.12 Future Challenges
- •12.13 Conclusion
- •References
- •13.1 Introduction
- •13.5 Central Compartment Neck Dissection
- •13.6 Selective Neck Dissection
- •13.7.1 Selective Neck Dissection
- •13.7.2 Case Illustration 1
- •13.7.3 Case Illustration 2
- •13.7.4 Case Illustration 3
- •13.9 Radical Neck Dissection
- •13.11 Prognosis
- •13.12 Conclusion
- •References
- •14.1 Introduction
- •14.3 Endoscopic Assisted Surgical Access
- •14.3.1 Endoscopic Thyroidectomy
- •14.7 Clavicle Osteotomy
- •14.7.1 Case Illustration
- •14.7.1.1 Case 1
- •14.8 Base-of-Neck Tumour
- •14.11 Conclusion
- •References
- •15.1 Introduction
- •15.2 Orbital Exenteration
- •15.2.1 Surgical Steps
- •15.2.1.1 Lid-Sparing Exenteration
- •15.2.1.2 Total Exenteration
- •15.2.2 Case Illustrations
- •15.2.3 Complications
- •15.4 Conclusion
- •References
- •16.1 Introduction
- •16.2.1 Benign Pathology
- •16.4 Vestibular Disorders
- •16.4.1 Ménière’s Disease
- •16.4.2 Superior Semicircular Canal Dehiscence
- •16.5.3 Temporal Bone Paraganglioma
- •16.6 Malignant Neoplasms
- •16.7.1 Diagnostic Audiology
- •16.7.2 Vestibular Tests
- •16.7.3 Imaging
- •16.8.2 Postauricular Incision
- •16.8.3 Transmeatal Incisions
- •16.8.4 Endaural Incisions
- •16.9 Anterior Atticotomy
- •16.10 Transmastoid Approaches
- •16.10.3 Posterior Tympanotomy
- •16.11 Endolymphatic Sac Decompression
- •16.12 Subtotal Petrosectomy
- •16.13 Translabyrinthine Approaches
- •16.14 Transcochlear Approach
- •16.16 Middle Cranial Fossa
- •16.19 Endoscopic Ear Surgery
- •16.19.1 Protympanum
- •16.19.2 Epitympanum
- •16.19.3 Retrotympanum
- •16.19.4 Hypotympanum
- •16.21 Conclusion
- •References
- •17.1 Introduction
- •17.2.1 Vascular Lesions
- •17.2.2 Infantile Haemangioma
- •17.2.2.1 Introduction
- •17.2.2.2 Epidemiology
- •17.2.2.3 Pathogenesis
- •17.2.2.4 Phases
- •17.2.2.4.1 Proliferative Phase
- •17.2.2.4.2 Involution Phase
- •17.2.2.5 Diagnosis
- •17.2.2.6 Treatment
- •17.2.2.7 Medical Therapy
- •17.2.2.8 Laser Therapy
- •17.2.2.9 Surgical Therapy
- •17.2.3 Dermoid Cyst
- •17.2.3.1 Introduction
- •17.2.3.3 Clinical Presentation
- •17.2.3.4 Imaging
- •17.2.3.5 Treatment
- •17.2.3.5.1 Surgery
- •17.3 Thyroglossal Duct Cyst
- •17.3.1 Introduction
- •17.3.2 Embryology
- •17.3.3 Clinical Presentation
- •17.3.4 Diagnosis
- •17.3.4.1 Blood Investigation
- •17.3.4.3 Histology
- •17.3.4.4 Imaging
- •17.3.5 Treatment
- •17.3.5.1 Surgery
- •17.3.5.2 Sclerotherapy
- •17.4 Rhabdomyosarcoma
- •17.4.1 Introduction
- •17.4.3 General Characteristics
- •17.4.4 Histology
- •17.4.5 Diagnosis
- •17.4.5.1 Biopsy
- •17.4.6 Staging
- •17.4.7 Treatment
- •17.4.7.1 Chemotherapy
- •17.4.7.2 Radiation Therapy
- •17.4.7.3 Surgical Therapy
- •17.4.8 Prognosis
- •17.4.9 Recurrence
- •17.5.1 Introduction
- •17.5.2 Epidemiology
- •17.5.3 Aetiology
- •17.5.4 Pathogenesis
- •17.5.5 Presentation
- •17.5.6 Diagnosis
- •17.5.7 Imaging
- •17.5.8 Histology
- •17.5.9 Staging
- •17.5.9.1 Fisch Staging
- •17.5.9.2 Radkowski Staging
- •17.5.10 Treatment
- •17.5.10.1 Surgery
- •17.5.10.2 Outcome
- •17.5.10.3 Complications
- •17.5.10.4 Radiotherapy
- •17.5.10.5 Chemotherapy
- •17.5.10.6 Hormonal Therapy
- •17.5.10.7 Spontaneous Regression
- •17.6 Lymphatic Malformation
- •17.6.1 Introduction
- •17.6.2 Genetics
- •17.6.3 Clinical Presentation
- •17.6.4 Diagnosis
- •17.6.5 Treatment
- •17.6.5.1 Observation
- •17.6.5.2 Sclerotherapy
- •17.6.5.3 Surgery
- •17.6.5.4 Other Modalities
- •17.6.5.4.1 Novel Agents
- •17.7 Cystic Hygroma
- •17.8 Lymphoma
- •17.8.1 Hodgkin’s Lymphoma
- •17.8.2 Non-Hodgkin’s Lymphoma
- •17.8.4 Diagnosis
- •17.8.4.1 Haematology
- •17.8.4.2 Imaging
- •17.8.4.3 Surgery
- •17.8.7.1 Radiation Therapy
- •17.9 Langerhans Cell Histiocytosis
- •17.9.1 Epidemiology
- •17.9.2 Pathogenesis
- •17.9.3 Clinical Feature
- •17.9.4 Investigations
- •17.9.5 Treatment
- •17.9.5.1 Solitary or Single-System Involvement
- •17.9.5.2 Multisystem Involvement
- •17.9.5.3 Induction Chemotherapy
- •17.9.5.4 Continuation Chemotherapy
- •17.9.5.5 Post-treatment Follow-Up
- •17.9.5.6 Relapsed or Refractory Disease
- •References
- •18.1.1 Case Illustration 1
- •18.1.2 Surgical Steps
- •18.2 Case Illustration 2
- •18.3 Stomatoplasty
- •18.5.1 Case Illustration
- •18.6.1 Case Illustration
- •18.7 Deep Lobe Parotidectomy
- •18.8 Conclusion
- •References
- •19.1 Introduction
- •19.2.1 Cross-Sectional Imaging
- •19.2.2 Emerging Applications
- •19.2.6 PET-MR
- •19.2.8 Others
- •19.2.8.1 SPECT
- •19.2.8.2 Elastography
- •19.2.8.3 Fluoroscopy
- •19.2.8.4 Narrowband Imaging
- •19.2.9 Biochemical Investigations
- •19.2.10 Imaging Biomarkers
- •19.3.1 Neck Dissection
- •19.5 Oral Cavity Cancer (OCSCC)
- •19.7 Hypopharyngeal Cancer
- •19.8 Nasopharynx Carcinoma (NPC)
- •19.10 Salivary Gland Malignancy
- •19.10.1 Parotid Tumors
- •19.11 Intraoperative Facial Nerve Monitoring
- •19.12.1 Treatment
- •19.13 Parapharyngeal Space Tumors (PPS)
- •19.14.2 Diagnostic Controversy
- •19.14.5 Optimal Resection Margins
- •19.15.1 Nonsurgical Treatment
- •19.16.2 Induction Chemotherapy
- •19.19.1 Targeted Therapy
- •19.19.2 Immunotherapy
- •19.19.3 Cancer Stem Cells (CSCs)
- •19.20 Conclusion
- •References

314
C. Saraniti and B. Verro
a
b
c
Fig. 12.18 (a) Contralateral rotation of the larynx, (b) dissection of the piriform sinus, (c) section of the suprahyoid
muscles’ insertion to the hyoid bone
Detachment of thyroid lobes from the
laryngeal-tracheal axis is performed.
Separate the two thyroid lobes by performing
an isthmotomy or isthmectomy, according to
need (Fig.12.17).
9. Ligature of the laryngeal pedicle
10. Contralateral rotation of the larynx with
positioning of the nger behind the thyroid
ala (Fig.12.18)
11. Section of the constrictor muscles along the
lateral edge of the thyroid ala up to the upper
cornu and, inferiorly, to detach the cricopharyngeal muscle
12. Blunt dissection of the piriform sinus via the
internal sub-perichondrium (Fig.12.18)
13. Section of the suprahyoid muscles’ insertion
to the hyoid bone (Fig.12.18)
14. Incision along the upper edge of the hyoid
bone from the body up to the large cornu
which are separated from the lateral walls of
the hypopharynx
15. Section of the hyo-glossus ligament
16. Tracheostomy
It is usually performed by including two
tracheal rings, between the second and the
third rings. If the tracheostomy was per-

12 Laryngeal Disease andTumours andIts Related Surgery
Fig. 12.19 Tracheotomy
formed previously, the tracheal section
should be performed inferiorly to the
previous tracheostomy, including only one
tracheal ring (Fig.12.19).
17. Detachment of larynx and trachea from
hypopharynx and oesophagus
Once the posterior membranous wall of
the trachea is dissected, the laryngo-tracheal
axis is detached by blunt dissection, from the
bottom upwards. Section of recurrent nerves
follows. Detachment can reach up to the
upper edge of the cricoid plate (Fig.12.20).
18. Pharyngotomy
This can be performed at the top along
the glosso-epiglottic fossae or, below, at
the height of the upper edge of the cricoid
in the interarytenoid region. At this point,
once the approach to the hypopharynx has
been chosen, the section must follow the
ary- epiglottic fold, curving medially along
the glosso- epiglottic fossae until it sur-
315
rounds the contralateral ary-epiglottic fold.
Access, upper or lower, is performed on
the side less affected by the tumour
(Fig.12.20).
19. Examination of the endolaryngeal tumour
Examination of endolaryngeal tumour’s
extension to evaluate the need of wider resections on its margins should be carried out.
20. Crico-pharyngeal myotomy
This step is critical in view of voice pros-
thesis placement. Before closing the pharynx, the nger is put at the level of the
pharyngotomy opening in order to stretch the
muscle that is dissected along the lateral wall
of the hypopharynx. This manoeuvre should
be performed carefully in order to dissect
only the muscle bres in order to spare the
underlying mucosa (Fig.12.20).
21. Tracheo-oesophageal stula
Tracheo-oesophageal stula and insertion of
voice prostheses can be performed (Fig.12.21).
22. Closure of the pharynx
The suture is performed in a T shape: the
horizontal branch along the upper edge of the
piriform sinuses and the vertical branch
along the retro-cricoid region (Fig. 12.22).
Usually, the suture is performed in inter-
rupted sutures and involves three layers:
(a) Inverting suture: mucosa-mucosa
(b) Submucosal-serous
(c) Constrictor muscle layer
This suture can also be performed in two
layers:
(a) Serous-serous
(b) Constrictor muscle layer
23. Packaging of the tracheostomy
Once the tracheal section is performed,
the anterior edge of the trachea is xed with
interrupted suture to the skin of the jugulum.
Laterally, the sternal head of the sternocleidomastoid muscle should be used to x the
tracheostomy in order to avoid possible

316
C. Saraniti and B. Verro
a
b
c
Fig. 12.20 (a) Detachment of larynx from hypopharynx and oesophagus, (b) pharyngotomy, (c) crico-pharyngeal
myotomy

12 Laryngeal Disease andTumours andIts Related Surgery
Fig. 12.21 Trache-oesophageal stula
317
Fig. 12.22 Closure of the pharynx

318
C. Saraniti and B. Verro
a
b
c
Fig. 12.23 Packaging of the tracheostomy including in a single suture point: (a) skin, (b) sternomastoid muscle, (c)
lateral part of the tracheal ring
circular stenosis of the tracheostoma or its
sliding behind the sternal manubrium and to
ensure stable attening of the tracheostoma:
this procedure is performed including the lateral part of the tracheal ring, the sternomastoid muscle and the skin in a single suture
point (Fig.12.23).
strategies and for swallowing difculties. This is
the reason why, in the last 50years, new strategies
have been theorized in order to recreate the organ
with its functions. In particular, implanting an articial laryngeal prosthesis has been hypothesized:
this experiment to date has only been performed
on animals with various serious complications
such as infections, erosion and migration of the
prosthesis with a serious danger to life [64]. In
12.12 Future Challenges
2001, Strome etal. performed a laryngeal trans-
plant on a male patient [65]. Forty months after
As previously written, in the case of total laryngectomy, there is a signicant impairment of
patient’s quality of life due to dependence on the
tracheostomy for breathing, for unnatural speech
transplant, the patient presented voice and swal-
lowing ability near to normal condition; but it was
not possible to close the tracheal stoma and restore
the normal and physiological airway.

12 Laryngeal Disease andTumours andIts Related Surgery
319
If to date the surgical techniques, in the case
of both OPHL and total laryngectomy, are well
dened and globally accepted, the strategies for
recreating the larynx post-total laryngectomy
have not yet been studied and the proposed
hypotheses are still in the initial stages of experimentation. Therefore, the future challenge is to
identify the best strategy to recover all laryngeal
functions near to normal.
12.13 Conclusion
The larynx performs important and difcult functions with an elegant simplicity [51]. Oncological
laryngeal surgery must be carried out with care
both in the demolition phase and in the reconstructive phase. So, two main objectives have to
be reached: radicality of resection and function
preservation guaranteeing the best quality of life
for the patient.
According to this, over the years, different
surgical techniques have been proposed in
order to couple a less demolitive surgery with
oncological radicality in order to limit total
laryngectomy as much as possible. For the
same reason, the strategies for phonatory and
respiratory rehabilitation are equally important and fruitful. Unfortunately, due to its fundamental role in three essential functions for
humans (breathing, speaking, eating), recreating the larynx remains the most difficult challenge but also the most important in order to
give back to the patient “simply” his/her
normality.
References
1. McCarrel TM, Woodie JB.Update on laryngeal disorders and treatment. Vet Clin North Am Equine
Pract. 2015;31(1):13–26. https://doi.org/10.1016/j.
cveq.2014.11.009.
2. Alonso JM. Conservative surgery of cancer of the
larynx. Trans Am Acad Ophthalmol Otolaryngol.
1947;51:633–42.
3. Rucci L. Testo Atlante di embriologia clinica della
Laringe. La chirurgia conservativa compartimentale
della regione glottica. Florence: Firenze University
Press; 2006.
4. Prades JM, Peoc’h M, Petcu C, Karkas A, Dumollard
JM, Gavid M.The anterior commissure of the human
larynx revisited. Surg Radiol Anat. 2017;39(8):871–6.
https://doi.org/10.1007/s00276- 017- 1814- 2.
5. Mor N, Blitzer A. Functional anatomy and oncologic barriers of the larynx. Otolaryngol Clin N
Am. 2015;48(4):533–45. https://doi.org/10.1016/j.
otc.2015.04.002.
6. Joo YH, Park JO, Cho KJ, Kim MS. Relationship
between paraglottic space invasion and cervical lymph
node metastasis in patients undergoing supracricoid
partial laryngectomy. Head Neck. 2012;34(8):1119–
22. https://doi.org/10.1002/hed.21892.
7. Tucker G Jr. Some clinical inferences
from the study of serial laryngeal sections.
Laryngoscope. 1963;73:728–748. https://doi.org/
10.1288/00005537-196306000-00010.
8. Sato K, Kurita S, Hirano M.Location of the preepiglottic space and its relationship to the paraglottic
space. Ann Otol Rhinol Laryngol. 1993;102(12):930–
4. https://doi.org/10.1177/000348949310201204.
9. Naunheim MR, Carroll TL. Benign vocal fold
lesions: update on nomenclature, cause, diagnosis,
and treatment. Curr Opin Otolaryngol Head Neck
Surg. 2017;25(6):453–8. https://doi.org/10.1097/
MOO.0000000000000408.
10. Stinnett S, Chmielewska M, Akst LM. Update on
management of hoarseness. Med Clin North Am.
2018;102(6):1027–40. https://doi.org/10.1016/j.
mcna.2018.06.005.
11. Tulli M, Re M, Bondi S, etal. The prognostic value of
anterior commissure involvement in T1 glottic cancer:
a systematic review and meta-analysis. Laryngoscope.
2019; https://doi.org/10.1002/lary.28395.
12. Chiesa Estomba CM, Betances Reinoso FA, Lorenzo
Lorenzo AI, Fariña Conde JL, Araujo Nores J,
Santidrian HC. Functional outcomes of supraglottic
squamous cell carcinoma treated by transoral laser
microsurgery compared with horizontal supraglottic
laryngectomy in patients younger and older than 65
years. Acta Otorhinolaryngol Ital. 2016;36(6):450–8.
https://doi.org/10.14639/0392- 100X- 864.
13. Gao P, Gong L, Wang X. Induction chemotherapy
in patients with resectable laryngeal cancer: a metaanalysis. Mol Clin Oncol. 2018;9(2):155–62. https://
doi.org/10.3892/mco.2018.1645.
14. Ferlay J, Soerjomataram I, Dikshit R, etal. Cancer
incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Int J Cancer. 2015;136(5):E359–86. https://doi.
org/10.1002/ijc.29210.
15. Ciolofan MS, Vlăescu AN, Mogoantă CA, et al.
Clinical, histological and Immunohistochemical
evaluation of larynx cancer. Curr Health Sci J.
2017;43(4):367–75. https://doi.org/10.12865/
CHSJ.43.04.14.
16. Horakova Z, Bretislav G, Karel V, Pazourkova M,
Urbanková P, Petr S.Non-squamous cell carcinomas of
the larynx madridge. J Otorhinolaryngol. 2018;3(1):41–
6. https://doi.org/10.18689/mjol- 1000108.

320
C. Saraniti and B. Verro
17. Yılmaz T, Süslü N, Atay G, Günaydın RÖ, Bajin MD,
Özer S.The effect of midline crossing of lateral supraglottic cancer on contralateral cervical lymph node
metastasis. Acta Otolaryngol. 2015;135(5):484–8.
https://doi.org/10.3109/00016489.2014.986759.
18. Elegbede AI, Rybicki LA, Adelstein DJ, et al.
Oncologic and functional outcomes of surgical and
nonsurgical treatment of advanced squamous cell carcinoma of the supraglottic larynx. JAMA Otolaryngol
Head Neck Surg. 2015;141(12):1111–7. https://doi.
org/10.1001/jamaoto.2015.0663.
19. Succo G, Bussi M, Presutti L, etal. Supratracheal laryngectomy: current indications and contraindications.
Acta Otorhinolaryngol Ital. 2015;35(3):146–56.
20. Tachibana T, Orita Y, Marunaka H, et al. Glottic
cancer in patients without complaints of hoarseness.
Head Neck. 2016;38(Suppl 1):E316–20. https://doi.
org/10.1002/hed.23992.
21. MacNeil SD, Patel K, Liu K, etal. Survival of patients
with subglottic squamous cell carcinoma. Curr
Oncol. 2018;25(6):e569–75. https://doi.org/10.3747/
co.25.3864.
22. Paul BC, Rai B, Achlatis S, Amin MR,
Branski RC. Morbidity and patient perception of exible laryngoscopy. Ann Otol Rhinol
Laryngol. 2012;121(11):708–13. https://doi.
org/10.1177/000348941212101102.
23. Cafer PP, Nawka T, Ibrahim-Nasr A, et al.
Development of three-dimensional laryngostroboscopy for ofce-based laryngeal diagnostics and phonosurgical therapy. Laryngoscope.
2018;128(12):2823–31. https://doi.org/10.1002/
lary.27260.
24. Ni XG, He S, Xu ZG, etal. Endoscopic diagnosis of
laryngeal cancer and precancerous lesions by narrow
band imaging. J Laryngol Otol. 2011;125(3):288–96.
https://doi.org/10.1017/S0022215110002033.
25. Piazza C, Del Bon F, Peretti G, Nicolai P.Narrow band
imaging in endoscopic evaluation of the larynx. Curr
Opin Otolaryngol Head Neck Surg. 2012;20(6):472–
6. https://doi.org/10.1097/MOO.0b013e32835908ac.
26. Banko B, Dukić V, Milovanović J, Kovač JD, Artiko
V, Maksimović R. Diagnostic signicance of magnetic resonance imaging in preoperative evaluation of patients with laryngeal tumors. Eur Arch
Otorhinolaryngol. 2011;268(11):1617–23. https://doi.
org/10.1007/s00405- 011- 1701- 0.
27. Bussu F, Paludetti G, Almadori G, etal. Comparison
of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities
in advanced laryngeal squamous cell carcinomas:
a multicenter retrospective analysis. Head Neck.
2013;35(4):554–61. https://doi.org/10.1002/
hed.22994.
28. Del Bon F, Piazza C, Lancini D, et al. Open partial horizontal laryngectomies for T3–T4 laryngeal cancer: prognostic impact of anterior vs.
posterior laryngeal compartmentalization. Cancers
(Basel). 2019;11(3):289. https://doi.org/10.3390/
cancers11030289.
29. Succo G, Crosetti E, Bertolin A, et al. Benets and
drawbacks of open partial horizontal laryngectomies,
part A: early- to intermediate-stage glottic carcinoma.
Head Neck. 2016;38(Suppl 1):E333–40. https://doi.
org/10.1002/hed.23997.
30. Gosepath J. Die verschiedenen Methoden der
Teilresektionen des Kehlkopfes [The various
methods of partial resection of the larynx]. HNO.
1972;20(8):227–40.
31. Succo G, Peretti G, Piazza C, et al. Open partial
horizontal laryngectomies: a proposal for classication by the working committee on nomenclature
of the European Laryngological Society. Eur Arch
Otorhinolaryngol. 2014;271(9):2489–96. https://doi.
org/10.1007/s00405- 014- 3024- 4.
32. Tomeh C, Holsinger FC.Laryngeal cancer. Curr Opin
Otolaryngol Head Neck Surg. 2014;22(2):147–53.
https://doi.org/10.1097/MOO.0000000000000032.
33. Lucioni M, Bertolin A, Lionello M, Giacomelli L,
Rizzotto G, Marioni G. Open partial horizontal laryngectomy for salvage after failure of CO2 laserassisted surgery for glottic carcinoma. Eur Arch
Otorhinolaryngol. 2016;273(1):169–75. https://doi.
org/10.1007/s00405- 015- 3734- 2.
34. Marioni G, Marchese-Ragona R, Kleinsasser NH,
etal. Partial laryngeal surgery in recurrent carcinoma.
Acta Otolaryngol. 2015;135(2):119–24. https://doi.
org/10.3109/00016489.2014.969811.
35. Benito J, Holsinger FC, Pérez-Martín A, Garcia
D, Weinstein GS, Laccourreye O. Aspiration after
supracricoid partial laryngectomy: incidence,
risk factors, management, and outcomes. Head
Neck. 2011;33(5):679–85. https://doi.org/10.1002/
hed.21521.
36. Succo G, Crosetti E. Limitations and opportunities
in open laryngeal organ preservation surgery: current
role of OPHLs. Front Oncol. 2019;9:408. https://doi.
org/10.3389/fonc.2019.00408.
37. Schindler A, Pizzorni N, Fantini M, etal. Long-term
functional results after open partial horizontal laryngectomy type IIa and type IIIa: a comparison study.
Head Neck. 2016;38(Suppl 1):E1427–35. https://doi.
org/10.1002/hed.24254.
38. de Vincentiis M, De Virgilio A, Bussu F, et al.
Oncologic results of the surgical salvage of recurrent
laryngeal squamous cell carcinoma in a multicentric
retrospective series: emerging role of supracricoid
partial laryngectomy. Head Neck. 2015;37(1):84–91.
https://doi.org/10.1002/hed.23563.
39. Paleri V, Thomas L, Basavaiah N, Drinnan M, Mehanna
H, Jones T.Oncologic outcomes of open conservation
laryngectomy for radiorecurrent laryngeal carcinoma:
a systematic review and meta-analysis of Englishlanguage literature. Cancer. 2011;117(12):2668–76.
https://doi.org/10.1002/cncr.25831.
40. Succo G, Crosetti E, Bertolin A, et al. Benets and
drawbacks of open partial horizontal laryngectomies,
part B: intermediate and selected advanced stage
laryngeal carcinoma. Head Neck. 2016;38(Suppl
1):E649–57. https://doi.org/10.1002/hed.24064.
41. Pinar E, Imre A, Calli C, Oncel S, Katilmis
H. Supracricoid partial laryngectomy: analyses of
oncologic and functional outcomes. Otolaryngol

12 Laryngeal Disease andTumours andIts Related Surgery
321
Head Neck Surg. 2012;147(6):1093–8. https://doi.
org/10.1177/0194599812457334.
42. Weinstein GS, El-Sawy MM, Ruiz C, et al.
Laryngeal preservation with supracricoid partial laryngectomy results in improved quality
of life when compared with total laryngectomy.
Laryngoscope. 2001;111(2):191–9. https://doi.
org/10.1097/00005537- 200102000- 00001.
43. Leszczyńska M, Wierzbicka M, Tokarski M, Szyfter
W.Attempt to improve functional outcomes in supracricoid laryngectomy in T2b and T3 glottic cancers.
Eur Arch Otorhinolaryngol. 2015;272(10):2925–31.
https://doi.org/10.1007/s00405- 014- 3244- 7.
44. Pescetto B, Gal J, Chamorey E, etal. Role of supracricoid partial laryngectomy with cricohyoidoepiglottopexy in glottic carcinoma with anterior commissure
involvement. Eur Ann Otorhinolaryngol Head Neck
Dis. 2018;135(4):249–53. https://doi.org/10.1016/j.
anorl.2018.05.004.
45. Brasnu DF. Supracricoid partial laryngectomy with
cricohyoidopexy in the management of laryngeal
carcinoma. World J Surg. 2003;27(7):817–23. https://
doi.org/10.1007/s00268- 003- 7116- 3.
46. Simonelli M, Ruoppolo G, de Vincentiis M, et al.
Swallowing ability and chronic aspiration after supracricoid partial laryngectomy. Otolaryngol Head Neck
Surg. 2010;142(6):873–8. https://doi.org/10.1016/j.
otohns.2010.01.035.
47. Succo G, Fantini M, Rizzotto G.Supratracheal partial laryngectomy: indications, oncologic and functional results. Curr Opin Otolaryngol Head Neck
Surg. 2017;25(2):127–32. https://doi.org/10.1097/
MOO.0000000000000344.
48. Rizzotto G, Crosetti E, Lucioni M, etal. Oncologic
outcomes of supratracheal laryngectomy: critical
analysis. Head Neck. 2015;37(10):1417–24. https://
doi.org/10.1002/hed.23773.
49. Hall FT, O’Brien CJ, Clifford AR, McNeil EB, Bron
L, Jackson MA.Clinical outcome following total laryngectomy for cancer. ANZ J Surg. 2003;73(5):300–
5. https://doi.org/10.1046/j.1445- 2197.2003.02562.x.
50. Steuer CE, El-Deiry M, Parks JR, Higgins KA,
Saba NF. An update on larynx cancer. CA Cancer
J Clin. 2017;67(1):31–50. https://doi.org/10.3322/
caac.21386.
51. Zenga J, Goldsmith T, Bunting G, Deschler DG.State
of the art: rehabilitation of speech and swallowing
after total laryngectomy. Oral Oncol. 2018;86:38–47.
https://doi.org/10.1016/j.oraloncology.2018.08.023.
52. Dziegielewski PT, O’Connell DA, Klein M, et al.
Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based
analysis of survival. J Otolaryngol Head Neck Surg.
2012;41(Suppl 1):S56–64.
53. Forastiere AA, Ismaila N, Lewin JS, et al. Use of
larynx- preservation strategies in the treatment of
laryngeal cancer: American Society of Clinical
Oncology clinical practice guideline update. J Clin
Oncol. 2018;36(11):1143–69. https://doi.org/10.1200/
JCO.2017.75.7385.
54. Strojan P, Haigentz M Jr, Bradford CR, et al.
Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell
carcinoma. Oral Oncol. 2013;49(4):283–6. https://
doi.org/10.1016/j.oraloncology.2012.11.002.
55. van Sluis KE, van der Molen L, van Son RJJH,
Hilgers FJM, Bhairosing PA, van den Brekel
MWM.Objective and subjective voice outcomes after
total laryngectomy: a systematic review. Eur Arch
Otorhinolaryngol. 2018;275(1):11–26. https://doi.
org/10.1007/s00405- 017- 4790- 6.
56. Elmiyeh B, Dwivedi RC, Jallali N, et al. Surgical
voice restoration after total laryngectomy: an overview. Indian J Cancer. 2010;47(3):239–47. https://doi.
org/10.4103/0019- 509X.64707.
57. Moukarbel RV, Doyle PC, Yoo JH, Franklin JH,
Day AM, Fung K. Voice-related quality of life
(V-RQOL) outcomes in laryngectomees. Head Neck.
2011;33(1):31–6. https://doi.org/10.1002/hed.21409.
58. Kapila M, Deore N, Palav RS, Kazi RA, Shah RP, Jagade
MV. A brief review of voice restoration following
total laryngectomy. Indian J Cancer. 2011;48(1):99–
104. https://doi.org/10.4103/0019- 509X.75841.
59. Ward EC, Bishop B, Frisby J, Stevens M.Swallowing
outcomes following laryngectomy and pharyngolaryngectomy. Arch Otolaryngol Head Neck
Surg. 2002;128(2):181–6. https://doi.org/10.1001/
archotol.128.2.181.
60. Robertson SM, Yeo JC, Dunnet C, Young D,
Mackenzie K.Voice, swallowing, and quality of life
after total laryngectomy: results of the west of Scotland
laryngectomy audit. Head Neck. 2012;34(1):59–65.
https://doi.org/10.1002/hed.21692.
61. Arenaz Búa B, Pendleton H, Westin U, Rydell
R. Voice and swallowing after total laryngectomy.
Acta Otolaryngol. 2018;138(2):170–4. https://doi.org
/10.1080/00016489.2017.1384056.
62. Hasan Z, Dwivedi RC, Gunaratne DA, Virk SA, Palme
CE, Riffat F. Systematic review and meta- analysis
of the complications of salvage total laryngectomy.
Eur J Surg Oncol. 2017;43(1):42–51. https://doi.
org/10.1016/j.ejso.2016.05.017.
63. Grover S, Swisher-McClure S, Mitra N, et al. Total
laryngectomy versus larynx preservation for T4a larynx cancer: patterns of care and survival outcomes.
Int J Radiat Oncol Biol Phys. 2015;92(3):594–601.
https://doi.org/10.1016/j.ijrobp.2015.03.004.
64. Debry C, Vrana NE, Dupret-Bories A.Implantation of
an articial larynx after total laryngectomy. N Engl
J Med. 2017;376(1):97–8. https://doi.org/10.1056/
NEJMc1611966.
65. Strome M, Stein J, Esclamado R, et al. Laryngeal
transplantation and 40-month follow-up. N Engl J
Med. 2001;344(22):1676–9. https://doi.org/10.1056/
NEJM200105313442204.

Neck Dissections inHead andNeck
Malignancy
13
NorhazaMat Lazim
13.1 Introduction
Treatment of neck in the setting of head and neck
cancer is crucial. Neck metastasis is a common
phenomenon in head and neck malignancy, especially in higher stage tumour, poorly differentiated tumours, and mucosal related malignancy. A
good control of the neck disease ensures better
treatment outcomes. The risk of neck recurrence
and distant spread of the tumour will be lessened.
It is a challenge to manage neck metastasis, as the
area of the neck is wide with multiple critical
neurovascular structures located in this region.
The neck node’s location also varies according to
levels I–VI of the neck nodes, which requires an
accurate decision on which neck levels require
dissection. Multiple factors need to be considered
including the detailed characteristics of the primary tumours, the patient factors, and the expertise/clinician factors.
The head and neck malignancy will spread
through the primary lymphatic drainage of the
echelon nodes, which mostly are to level I–VI
neck nodes (Fig. 13.1). The primary area of
drainage is critical in determining the neck node
involvement. Certain subsites of head and neck
malignancy have different predilection of neck
node levels. For instance, oral cavity carcinoma
metastasizes to level I–III neck nodes.
Oropharyngeal and hypopharyngeal carcinomas
metastasize to level II–IV neck nodes. In comparison, laryngeal carcinoma spreads to level VI
and nasopharyngeal carcinoma metastasizes to
level V mostly (Table13.1).
A meticulous clinical examination is necessary
in order to rule out neck metastases. This is especially true in the setting of head and neck cancer
patients who had received chemoradiation as primary treatment. The neck tends to get brosed and
thickened due to granulation tissue; hence, neck
N. Mat Lazim (*)
Department of Otorhinolaryngology-Head and Neck
Surgery, School of Medical Sciences, Universiti Sains
Malaysia, Health Campus, Kubang Kerian,
Kelantan, Malaysia
e-mail: norhaza@usm.my
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022
N. Mat Lazim et al. (eds.), Head and Neck Surgery : Surgical Landmark and Dissection Guide,
https://doi.org/10.1007/978-981-19-3854-2_13
Fig. 13.1 Neck node levels I–VI harbour critical structures of the neck
323

324
Table 13.1 Lymphatic drainage of head and neck anatomic subsites
Anatomic region Lymphatic drainage area
1. Oral cavity
• Anterior two-third tongue buccal mucosa
• Floor of mouth
• Hard palate
• Gingiva
• Retromolar trigone
2. Oropharyngeal
• Base of tongue
• Tonsils
• Lateral pharyngeal wall
3. Pharyngeal
• Posterior pharyngeal wall
• Lateral pharyngeal wall
• Pyriform sinus
• Post-cricoid area
4. Salivary glands
• Parotid glands
• Submandibular glands
• Sublingual glands
5. Nasal cavity
• Paranasal sinuses
• Nasopharynx
6. • Thyroid glands
• Parathyroid glands
7. Laryngeal
• Supraglottic
• Glottic
• Subglottic
8. • Temporal bone
• EAC
• Pinna
Generally levels I–III
Level Ia
Level Ib
Level II
Level III
Level II
Level III
Level II
Level III
Level IV
Level IIa
Level IIb
Level III
Level IV
Level II
Level III
Level IV
Level I
Level Ib
Level II
Level III
Level IV
Level V
Level VI
Level II
Level III
Level IV
Level VI
Parotid nodes
Occipital nodes
Level V
N. Mat Lazim
palpation is more challenging. In a suspicious neck
mass, the supplementary assessment tool like ultrasound and CT scan would offer a great help. Blood
parameters such as tumour marker will provide
additional value for clinical suspicion of certain
types of head and neck malignancy. Thyroglobulin
is a tumour marker for papillary thyroid carcinoma,
whereas calcitonin is the tumour marker for medullary thyroid carcinoma. Serum calcium level, LDH,
and ALP are good markers of bony metastases.
Clinical examination of neck nodes will require
the documentation of size, location, multiplicity,
consistency, and xation (to underlying structures
and supercial skin). The endoscopic examination
of nasal cavity, nasopharynx, oral cavity and oropharynx, and laryngeal anatomic site will complement the ndings in order to rule out the primary
tumour. A better and accurate delineation of the
detailed morphology of the neck nodes can be
obtained from the imaging tools. Conrming a
lymph node metastasis requires not only quantitative measurements, but also the absence of fatty
hilum, blood ow, presence of cystic or coagulation necrosis, and peripheral capsular vascularization in a clinical setting. In addition, it is well
known that level I and II lymph nodes are larger
than those at the other levels [1]. Typical characteristics of lymph nodes suggestive of malignancy
are highlighted in Table13.2.
The most commonly used imaging modalities for
detecting cervical lymph node metastasis in patients
with HNC are CT scan and MRI. The minimum
axial diameter measurements of suspicious nodes
are useful for evaluating the metastases. A minimal
axial diameter of 10mm was considered to be the
best size criterion for MRI and 12mm for CT.Other
Соседние файлы в папке Библиотека им академика М.И. Перельмана
